↓ Skip to main content

Fluphenazine decanoate (depot) and enanthate for schizophrenia

Overview of attention for article published in Cochrane database of systematic reviews, February 2015
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age

Mentioned by

twitter
3 tweeters

Citations

dimensions_citation
6 Dimensions

Readers on

mendeley
136 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Fluphenazine decanoate (depot) and enanthate for schizophrenia
Published in
Cochrane database of systematic reviews, February 2015
DOI 10.1002/14651858.cd000307.pub2
Pubmed ID
Authors

Maayan N, Quraishi SN, David A, Jayaswal A, Eisenbruch M, Rathbone J, Asher R, Adams CE

Abstract

Intramuscular injections (depot preparations) offer an advantage over oral medication for treating schizophrenia by reducing poor compliance. The benefits gained by long-acting preparations, however, may be offset by a higher incidence of adverse effects.

Twitter Demographics

The data shown below were collected from the profiles of 3 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 136 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Canada 1 <1%
Unknown 135 99%

Demographic breakdown

Readers by professional status Count As %
Student > Master 28 21%
Student > Ph. D. Student 19 14%
Unspecified 17 13%
Researcher 14 10%
Student > Doctoral Student 14 10%
Other 44 32%
Readers by discipline Count As %
Medicine and Dentistry 49 36%
Unspecified 21 15%
Nursing and Health Professions 15 11%
Psychology 14 10%
Pharmacology, Toxicology and Pharmaceutical Science 11 8%
Other 26 19%

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 02 July 2015.
All research outputs
#2,633,919
of 5,307,856 outputs
Outputs from Cochrane database of systematic reviews
#6,347
of 7,855 outputs
Outputs of similar age
#82,932
of 164,765 outputs
Outputs of similar age from Cochrane database of systematic reviews
#186
of 213 outputs
Altmetric has tracked 5,307,856 research outputs across all sources so far. This one is in the 47th percentile – i.e., 47% of other outputs scored the same or lower than it.
So far Altmetric has tracked 7,855 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 13.3. This one is in the 17th percentile – i.e., 17% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 164,765 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 45th percentile – i.e., 45% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 213 others from the same source and published within six weeks on either side of this one. This one is in the 10th percentile – i.e., 10% of its contemporaries scored the same or lower than it.